COMMUNIQUÉS West-GlobeNewswire

Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
20/10/2026
Study launched earlier this year is expected to confirm previous efficacy signal in 2L KRAS-mutant MSS colorectal cancer study that saw 17 months PFS vs. 6 months for the historical standard of care SAN DIEGO, Oct. 20, [...]
Five Years After Netflix’s ‘Sex, Love & Goop,’ Darshana Avila Announces ‘It’s My Pleasure’ Women’s Retreat
20/10/2026
The sexological bodyworker featured on the series says the conversation about women's sexual health has opened up since 2021, even as social media keeps shutting it down. Oakland, CA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- [...]
As Autism and ADHD Diagnoses Surge, Love on the Autism Spectrum Offers Free Sessions for Long-Married Couples Who Never Had a Name for It
20/10/2026
Late-identified at 57 and with her partner more than 40 years, couples specialist Barbara "Blaze" Lazarony says the crisis isn't the diagnosis. It's the decades of marriage spent without one. Pacific Grove, CA, Oct. 20 [...]
Applied AI Company Baba Raises $40 Million Series A to Improve the Medicare Experience
20/10/2026
Round led by FirstMark Capital, with CVS Health Ventures and Valtruis joining returning investors General Catalyst, Genius Ventures and Ground Up Ventures Funding will expand Baba’s clinical care teams, advance its AI [...]
MyCardiologist Opens New Ambulatory Care Center in Miami Lakes, Expanding Access to Outpatient Cardiovascular Care
20/10/2026
MyCardiologist Ambulatory Care Center provides specialized cardiovascular procedures in an outpatient setting and strengthens MyCardiologist’s ability to care for patients throughout South Florida MIAMI LAKES, Fla., Oct [...]
ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
20/10/2026
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led [...]
Correction: ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
20/10/2026
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led [...]
Slate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young
20/10/2026
RALEIGH, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Slate Medicines, Inc. (“Slate”), a clinical-stage biotechnology company committed to advancing innovative new therapies that may broaden the treatment paradigm and [...]
Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026
20/10/2026
Correlation between clinical efficacy and changes in inflammatory biomarkers, mucosal transcriptomic signatures, and histologic disease activity strengthens the previously shown clinical proof of concept for OD-001 [...]
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
20/10/2026
85% year-over-year scan volume growth in Q3 2026, contributing to 117% growth for the nine months ended September 30, 2026 European Spine Journal publishes peer-reviewed data supporting MRS as a potential viable [...]
PolarityBio Highlights Highest Scoring Abstract Award and Presentation of Phase 3 COVER DFUS II Trial Results at SAWC Fall 2026
20/10/2026
“Autologous Cutaneous Multicellular Units in Non-Healing Wagner 1 Diabetic Foot Ulcers: Results of the Phase 3 COVER DFUS II Trial” honored with top award in Clinical Research category Pivotal Phase 3 trial met primary [...]
Mammogen Names National Cancer Screening Leader, Dr. Rebecca Kaltman, to Lead Pivotal genTRU-breast™ Study
20/10/2026
Executive Director of the Inova Saville Cancer Screening and Prevention Center will lead KATELYN-ERIN, Mammogen’s large prospective study evaluating its blood-based RNA assay to support breast cancer detection NEWPORT [...]
Kane Biotech Signs Distribution Agreement with The Stevens Company
20/10/2026
Expands Kane Biotech’s commercial footprint and access to the revyve ® product line across Canada WINNIPEG, Manitoba, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane [...]
Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
20/10/2026
BOSTON, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases [...]
Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026
20/10/2026
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on [...]
The Consortium for Top-Down Proteomics is now The Proteoform Alliance, with the Expanded Mission to Unlock the Full Potential of Proteoform Biology
20/10/2026
Proteoforms are the primary effectors of biological function, and uniting the various technologies, applications, and institutions in one organization will greatly increase our knowledge and capabilities for proteoform- [...]
Medicovestor Announces FDA Fast Track Designation for MC001, Its First-in-Class Chemoimmunotherapy ADC for Pancreatic Cancer
20/10/2026
Designation follows recent IND activation and builds on Orphan Drug Designation granted in 2025. NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Medicovestor, Inc. today announced that the US Food and Drug Administration ( [...]
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
20/10/2026
ST. LOUIS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release [...]
Philips highlights Integrated Diagnostics’ role in the future of cardiovascular informatics following MediReport acquisition
20/10/2026
October 20, 2026 Advanced reporting and workflow capabilities developed by MediReport are expected to complement Philips’ cardiovascular informatics portfolio and support its evolution toward a more connected, AI- [...]

Pages